SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-070568
Filing Date
2024-06-07
Accepted
2024-06-07 16:02:02
Documents
15
Period of Report
2024-06-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20240605.htm   iXBRL 8-K 122989
2 EX-3.1 acet-ex3_1.htm EX-3.1 9794
3 EX-3.2 acet-ex3_2.htm EX-3.2 11388
4 EX-3.3 acet-ex3_3.htm EX-3.3 51805
5 EX-10.1 acet-ex10_1.htm EX-10.1 148718
  Complete submission text file 0000950170-24-070568.txt   507240

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20240605.xsd EX-101.SCH 25999
19 EXTRACTED XBRL INSTANCE DOCUMENT acet-20240605_htm.xml XML 4934
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 241029182
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)